Lanean...
Beyond PSA: The next generation of prostate cancer biomarkers
Since the introduction of serum prostate specific antigen (PSA) screening twenty-five years ago, prostate cancer diagnosis and management have been guided by this biomarker. Yet, PSA has proven controversial as a diagnostic assay due to its limitations. The next wave of prostate cancer biomarkers ha...
Gorde:
Egile Nagusiak: | , , , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
2012
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3799996/ https://ncbi.nlm.nih.gov/pubmed/22461644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003180 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|